Alyeska Investment Group’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Hold
0
719
2024
Q2
Hold
0
667
2024
Q1
Hold
0
630
2023
Q4
Hold
0
653
2023
Q3
Hold
0
633
2023
Q2
Hold
0
611
2021
Q3
Sell
-4,000
Closed -$989K 824
2021
Q2
$989K Hold
4,000
0.01% 586
2021
Q1
$975K Buy
+4,000
New +$975K 0.01% 586